SUBSCRIBE
SUBSCRIBE

Funding

Pictured: Falling Pain Pill Bottles / Taylor Tiede
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
 · 
3 min read
 · 
Heather McKenzie
Load More
PRESS RELEASES
Press Releases
Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines
January 13, 2026
 · 
3 min read
Press Releases
Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering
January 13, 2026
 · 
4 min read
Press Releases
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery
January 13, 2026
 · 
4 min read
Press Releases
Inquis Medical Announces $75 Million Series C Financing to Scale Commercial Adoption of its AVENTUS Thrombectomy System
January 13, 2026
 · 
2 min read
Press Releases
Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline
January 13, 2026
 · 
3 min read
Press Releases
Trailhead Biosystems Expands Financing to $40 Million
January 13, 2026
 · 
2 min read
Press Releases
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
January 13, 2026
 · 
4 min read
Press Releases
Lung Cancer Research Foundation Announces 2026 Requests for Proposals
January 13, 2026
 · 
4 min read
Press Releases
Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development
January 13, 2026
 · 
7 min read
Press Releases
Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors
January 12, 2026
 · 
3 min read
Press Releases
Cytotheryx Secures Lead Investor for $60M Series A; Confirms Debt Financing to Expand Facilities
January 12, 2026
 · 
2 min read
Press Releases
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
January 12, 2026
 · 
3 min read
Press Releases
Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer
January 12, 2026
 · 
4 min read
Press Releases
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
January 12, 2026
 · 
9 min read
Press Releases
Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
January 12, 2026
 · 
4 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
 · 
6 min read
Press Releases
Clene Announces Registered Direct Offering of Over $28 Million
January 9, 2026
 · 
10 min read
Press Releases
MEDIPOST Inc. Announces $140 Million in Funding to Accelerate Late-Stage Clinical Development
January 9, 2026
 · 
2 min read
Press Releases
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
January 9, 2026
 · 
3 min read
Press Releases
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
January 9, 2026
 · 
2 min read
Load More